Compartmentalized biosynthesis of mycophenolic acid
- PMID: 31209052
- PMCID: PMC6613074
- DOI: 10.1073/pnas.1821932116
Compartmentalized biosynthesis of mycophenolic acid
Abstract
Mycophenolic acid (MPA) from filamentous fungi is the first natural product antibiotic to be isolated and crystallized, and a first-line immunosuppressive drug for organ transplantations and autoimmune diseases. However, some key biosynthetic mechanisms of such an old and important molecule have remained unclear. Here, we elucidate the MPA biosynthetic pathway that features both compartmentalized enzymatic steps and unique cooperation between biosynthetic and β-oxidation catabolism machineries based on targeted gene inactivation, feeding experiments in heterologous expression hosts, enzyme functional characterization and kinetic analysis, and microscopic observation of protein subcellular localization. Besides identification of the oxygenase MpaB' as the long-sought key enzyme responsible for the oxidative cleavage of the farnesyl side chain, we reveal the intriguing pattern of compartmentalization for the MPA biosynthetic enzymes, including the cytosolic polyketide synthase MpaC' and O-methyltransferase MpaG', the Golgi apparatus-associated prenyltransferase MpaA', the endoplasmic reticulum-bound oxygenase MpaB' and P450-hydrolase fusion enzyme MpaDE', and the peroxisomal acyl-coenzyme A (CoA) hydrolase MpaH'. The whole pathway is elegantly comediated by these compartmentalized enzymes, together with the peroxisomal β-oxidation machinery. Beyond characterizing the remaining outstanding steps of the MPA biosynthetic steps, our study highlights the importance of considering subcellular contexts and the broader cellular metabolism in natural product biosynthesis.
Keywords: biosynthesis; compartmentalization; fungal natural product; mycophenolic acid; peroxisomal β-oxidation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Bentley R., Mycophenolic acid: A one hundred year odyssey from antibiotic to immunosuppressant. Chem. Rev. 100, 3801–3826 (2000). - PubMed
-
- Marzano A. V., Dassoni F., Caputo R., Treatment of refractory blistering autoimmune diseases with mycophenolic acid. J. Dermatolog. Treat. 17, 370–376 (2006). - PubMed
-
- de Winter B. C., van Gelder T., Therapeutic drug monitoring for mycophenolic acid in patients with autoimmune diseases. Nephrol. Dial. Transplant. 23, 3386–3388 (2008). - PubMed
-
- Jonsson C. A., Carlsten H., Mycophenolic acid inhibits inosine 5′-monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells. Int. Immunopharmacol. 3, 31–37 (2003). - PubMed
-
- Geris R., Simpson T. J., Meroterpenoids produced by fungi. Nat. Prod. Rep. 26, 1063–1094 (2009). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
